1. Home
  2. RDW vs DAWN Comparison

RDW vs DAWN Comparison

Compare RDW & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Redwire Corporation

RDW

Redwire Corporation

HOLD

Current Price

$9.27

Market Cap

1.4B

Sector

Industrials

ML Signal

HOLD

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$12.72

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDW
DAWN
Founded
2020
2018
Country
United States
United States
Employees
750
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
RDW
DAWN
Price
$9.27
$12.72
Analyst Decision
Buy
Strong Buy
Analyst Count
7
9
Target Price
$12.83
$27.11
AVG Volume (30 Days)
15.6M
1.7M
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$158,182,000.00
Revenue This Year
$38.80
$53.52
Revenue Next Year
$17.95
$27.10
P/E Ratio
N/A
N/A
Revenue Growth
N/A
20.60
52 Week Low
$4.87
$5.64
52 Week High
$22.25
$13.20

Technical Indicators

Market Signals
Indicator
RDW
DAWN
Relative Strength Index (RSI) 49.91 61.59
Support Level $7.05 $6.40
Resistance Level $10.06 $13.20
Average True Range (ATR) 0.81 0.79
MACD 0.08 -0.06
Stochastic Oscillator 59.83 91.75

Price Performance

Historical Comparison
RDW
DAWN

About RDW Redwire Corporation

Redwire Corp is engaged in mission-critical space solutions and reliable components for the next-generation space economy. It assists its customers in solving the complex challenges of future space missions and industries. The company's space infrastructure offerings include a broad array of modern products and services, which have been enabling space missions. The company's plan enables it to combine decades of flight heritage with a culture creating new technologies that are the building blocks of space infrastructure for government and commercial customers.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: